Breathe Well Live Well
|
Vectura Path Clearer In US As VR315 EU Launch Nears
Wall Street Journal LN) asthma blockbuster Advair. Novartis AG's (NOVN.VX) generics unit Sandoz relinquished the US rights to VR315 in March amid uncertainty about the … |
View full post on asthma – Google News
 CBC.ca |
Asthma 'spike' looms as school year nears
CBC.ca The annual asthma flare-up accounts for an estimated 25 per cent of children's emergency room admissions in September, according to the BC Lung Association. … |
View full post on asthma – Google News